|Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery Program|
“Over the past six years, our integrated respiratory program with Chiesi
has been extremely productive,” said
Through their continued partnership, Charles River will provide Chiesi an extensive portfolio of integrated drug discovery capabilities, including medicinal chemistry, ADME/DMPK studies, pharmaceutics, in vitro assays, in vivo models, and safety pharmacology studies to help identify and test Chiesi’s promising candidates for preclinical development.
“Charles River has a long track record in conducting inhaled drug
discovery and development studies,” said Dr.
Charles River and Chiesi have engaged in an ongoing program since 2011, with the latest extension paving the way for a durable continuation. In addition to their longstanding relationship with Chiesi, Charles River has been active in the respiratory research space for more than 16 years. In that time, Charles River’s scientists have been named as co-inventors on nearly 70 respiratory patents filed by their clients and produced 25 development candidates.
About Chiesi Farmaceutici
Headquartered in Parma,
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Charles River Laboratories International, Inc.